Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses and Other Current Liabilities

v3.19.2
Accrued Expenses and Other Current Liabilities
6 Months Ended
Jun. 30, 2019
Accrued Expenses and Other Current Liabilities  
Accrued Expenses and Other Current Liabilities

Note 8. Accrued Expenses and Other Current Liabilities

Accrued expenses consist of the following:

 

 

 

 

 

 

 

 

    

June 30, 2019

    

December 31, 2018

 

 

 

 

 

Drugs and clinical trial expenses

 

$

2,131

 

$

1,887

Accrued salaries, benefits and travel related costs

 

 

823

 

 

774

Professional and consultant fees

 

 

282

 

 

181

Legal expenses

 

 

130

 

 

105

Other administrative accruals

 

 

 5

 

 

109

 

 

$

3,371

 

$

3,056